Omnitrope FDA Approval History
FDA Approved: Yes (First approved May 30, 2006)
Brand name: Omnitrope
Generic name: somatropin (rDNA origin)
Dosage form: Injection
Company: Sandoz
Treatment for: Adult Human Growth Hormone Deficiency, Pediatric Growth Hormone Deficiency
Omnitrope (somatropin) is a recombinant human growth hormone indicated for treatment of children with growth failure due to growth hormone deficiency GHD and treatment of adults with either adult onset or childhood onset GHD.
Development timeline for Omnitrope
| Date | Article |
|---|---|
| Sep 3, 2008 | Approval Sandoz Receives FDA Approval for Omnitrope Pen 10 With Liquid Cartridge |
| Sep 14, 2005 | Sandoz Files Lawsuit Seeking FDA Ruling on Omnitrope |
| Sep 2, 2004 | FDA Defers Decision on Omnitrope Application |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
